G1 Therapeutics (GTHX) began trading on the Nasdaq on 18 May 2017

G1 Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel small molecule therapeutics for the treatment of patients with cancer in the United States.

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 44
• Headquarters: Research Triangle Park, North Carolina
• Founded: 2008
• http://www.g1therapeutics.com

• One week later: